Profile: The Female Health Company (FHCO.O)

The Female Health Company (FHC), incorporated in 1971, manufactures, markets and sells the FC2 female condom. FC2 provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS). In October 2009, the Company completed the transition from its first-generation product FC1 to its second generation product FC2, and production of FC1 ceased. FC2 became available in the United States in August 2009. FC2 is available in approximately 105 countries. It is sold directly to consumers in eight countries.

The FC2 female condom is made of a nitrile polymer. The FC2 female condom is the only food and drug administration (FDA) approved and marketed product controlled by women. On March 10, 2009, FC2 received FDA approval as a Class III medical device. FC2 is pre-lubricated and disposable.

The Company competes with Medtech Products Ltd. and PATH.